BRPI0910461A8 - hormônio de estimulação do folículo recombinante, sua composição farmacêutica, seu método de produção e seu uso. - Google Patents

hormônio de estimulação do folículo recombinante, sua composição farmacêutica, seu método de produção e seu uso.

Info

Publication number: BRPI0910461A8
Authority: BR; Brazil
Prior art keywords: pharmaceutical composition; production method; recombinant follicle; stimulation hormone; follicle stimulation
Prior art date: 2008-04-16

Application number

BRPI0910461A

Other languages

English (en)

Inventor

Plaksin Daniel

Cottingham Ian

Boyd White Richard

Original Assignee

Ferring Int Center Sa

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2008-04-16

Filing date

2009-04-16

Publication date

2018-10-16

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=39717519&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BRPI0910461(A8) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2009-04-16 Application filed by Ferring Int Center Sa filed Critical Ferring Int Center Sa

2018-03-27 Publication of BRPI0910461A2 publication Critical patent/BRPI0910461A2/pt

2018-10-16 Publication of BRPI0910461A8 publication Critical patent/BRPI0910461A8/pt

2021-02-23 Publication of BRPI0910461B1 publication Critical patent/BRPI0910461B1/pt

2021-05-25 Publication of BRPI0910461B8 publication Critical patent/BRPI0910461B8/pt

Links

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/59—Follicle-stimulating hormone [FSH]; Chorionic gonadotropins, e.g.hCG [human chorionic gonadotropin]; Luteinising hormone [LH]; Thyroid-stimulating hormone [TSH]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/24—Follicle-stimulating hormone [FSH]; Chorionic gonadotropins, e.g. HCG; Luteinising hormone [LH]; Thyroid-stimulating hormone [TSH]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/06—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/10—Drugs for disorders of the endocrine system of the posterior pituitary hormones, e.g. oxytocin, ADH
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/10—Transferases (2.)
- C12N9/1048—Glycosyltransferases (2.4)
- C12N9/1081—Glycosyltransferases (2.4) transferring other glycosyl groups (2.4.99)
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y204/00—Glycosyltransferases (2.4)
- C12Y204/99—Glycosyltransferases (2.4) transferring other glycosyl groups (2.4.99)
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y204/00—Glycosyltransferases (2.4)
- C12Y204/99—Glycosyltransferases (2.4) transferring other glycosyl groups (2.4.99)
- C12Y204/99006—N-Acetyllactosaminide alpha-2,3-sialyltransferase (2.4.99.6)
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Organic Chemistry (AREA)
Endocrinology (AREA)
General Health & Medical Sciences (AREA)
Zoology (AREA)
Engineering & Computer Science (AREA)
Genetics & Genomics (AREA)
Medicinal Chemistry (AREA)
Bioinformatics & Cheminformatics (AREA)
Biochemistry (AREA)
Reproductive Health (AREA)
Gastroenterology & Hepatology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Molecular Biology (AREA)
Biophysics (AREA)
Wood Science & Technology (AREA)
Public Health (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Animal Behavior & Ethology (AREA)
Toxicology (AREA)
General Engineering & Computer Science (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Biomedical Technology (AREA)
Biotechnology (AREA)
Diabetes (AREA)
Immunology (AREA)
Epidemiology (AREA)
Microbiology (AREA)
Plant Pathology (AREA)
Physics & Mathematics (AREA)
Gynecology & Obstetrics (AREA)
Pregnancy & Childbirth (AREA)
Peptides Or Proteins (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)

BRPI0910461A 2008-04-16 2009-04-16 hormônio de estimulação do folículo recombinante, sua composição farmacêutica, seu método de produção e seu uso BRPI0910461B8 (pt)

Applications Claiming Priority (5)

Application Number	Priority Date	Filing Date	Title
US4542408P	2008-04-16	2008-04-16
US61/045,424		2008-04-16
EP08251528.9		2008-04-25
EP08251528		2008-04-25
PCT/GB2009/000978 WO2009127826A1 (en)	2008-04-16	2009-04-16	Recombinant fsh including alpha 2,3- and alpha 2,6-sialylation

Publications (4)

Publication Number	Publication Date
BRPI0910461A2 BRPI0910461A2 (pt)	2018-03-27
BRPI0910461A8 true BRPI0910461A8 (pt)	2018-10-16
BRPI0910461B1 BRPI0910461B1 (pt)	2021-02-23
BRPI0910461B8 BRPI0910461B8 (pt)	2021-05-25

Family

ID=39717519

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
BRPI0910461A BRPI0910461B8 (pt)	2008-04-16	2009-04-16	hormônio de estimulação do folículo recombinante, sua composição farmacêutica, seu método de produção e seu uso

Country Status (29)

Country	Link
US (6)	US8951967B2 (pt)
EP (7)	EP3045471B1 (pt)
JP (7)	JP2011519359A (pt)
KR (5)	KR20160056960A (pt)
CN (3)	CN105906703A (pt)
AR (1)	AR071479A1 (pt)
AU (5)	AU2009237479B2 (pt)
BR (1)	BRPI0910461B8 (pt)
CA (1)	CA2725257A1 (pt)
CY (1)	CY1115413T1 (pt)
DK (6)	DK2808340T3 (pt)
ES (5)	ES2468318T3 (pt)
FI (4)	FI3098234T3 (pt)
FR (3)	FR17C1020I2 (pt)
HR (5)	HRP20140535T1 (pt)
HU (9)	HUE068565T2 (pt)
IL (2)	IL208538A (pt)
LT (8)	LT2808340T (pt)
MX (3)	MX355457B (pt)
NO (4)	NO2017025I1 (pt)
NZ (1)	NZ588381A (pt)
PL (6)	PL3144318T3 (pt)
PT (6)	PT3045471T (pt)
RU (3)	RU2682270C2 (pt)
SA (1)	SA109300228B1 (pt)
SI (6)	SI2268666T1 (pt)
TW (1)	TWI488640B (pt)
WO (1)	WO2009127826A1 (pt)
ZA (1)	ZA201007373B (pt)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
TWI488640B (zh)	2008-04-16	2015-06-21	菲瑞茵國際中心股份有限公司	藥學製劑
TWI532495B (zh)	2009-10-05	2016-05-11	菲瑞茵國際中心股份有限公司	藥學製劑
EP2417982A1 (en)	2010-07-30	2012-02-15	Ferring B.V.	Stabilization of gonadotropins
WO2012016576A1 (en) *	2010-08-04	2012-02-09	Glycotope Gmbh	Improved recombinant human follicle-stimulating hormone
PT2621517E (pt)	2010-09-29	2015-10-16	Ferring Bv	Composição para uso no tratamento da infertilidade
WO2012050175A1 (ja)	2010-10-15	2012-04-19	日本ケミカルリサーチ株式会社	糖鎖の非還元末端がマンノース残基である糖蛋白質の製造方法
PL2691119T3 (pl)	2011-03-31	2019-01-31	Ferring B.V.	Preparat farmaceutyczny
EP2717904A1 (en)	2011-06-06	2014-04-16	Ferring BV	Pharmaceutical preparation comprising recombinant fsh
JO3092B1 (ar) *	2011-08-08	2017-03-15	Ferring Bv	مركب لتحفيز مسيطر عليه للمبيض
WO2013093760A2 (en) *	2011-12-19	2013-06-27	Grifols, S.A.	Compositions, methods, and kits for preparing sialylated recombinant proteins
US9657310B2 (en) *	2012-04-27	2017-05-23	Jcr Pharmaceuticals Co., Ltd.	Expression vector
EP2824176A1 (en)	2013-07-11	2015-01-14	Siamed'xpress	Methods for producing sialylated therapeutic proteins
JP6652334B2 (ja) *	2014-05-31	2020-02-19	Ｊｃｒファーマ株式会社	ウリジンとｎ−アセチル−ｄ−マンノサミンとを含有する培地
WO2016102436A1 (en) *	2014-12-22	2016-06-30	F. Hoffmann-La Roche Ag	Cmp-dependent sialidase activity
EP3283097B1 (en)	2015-04-17	2020-02-12	Ferring B.V.	Fsh for treatment of infertility
MY179524A (en)	2015-06-26	2020-11-10	Ferring Bv	Methods of purification and/or viral inactivation
EP3205719A1 (en) *	2016-02-15	2017-08-16	CEVEC Pharmaceuticals GmbH	Cell lines for producing recombinant glycoproteins with di-antennary n-glycans, methods using the same, and recombinant glycoproteins
GB201603280D0 (en)	2016-02-24	2016-04-13	Ferring Bv	Stable liquid gonadotropin formulation
EP3382014A1 (en) *	2017-03-29	2018-10-03	CEVEC Pharmaceuticals GmbH	Recombinant glycoproteins with reduced antennary fucosylation
EP3441471A1 (en)	2017-08-08	2019-02-13	CEVEC Pharmaceuticals GmbH	Use of constitutively active variants of growth factor receptors as selection makers for the generation of stable producer cell lines
MX2020002235A (es)	2017-09-01	2020-07-20	Ferring Bv	Composicion para la estimulacion ovarica controlada.
HUE071268T2 (hu)	2018-04-30	2025-08-28	Ferring Bv	Készítmény szabályozott petefészek-stimuláláshoz
TWI846743B (zh)	2018-10-17	2024-07-01	荷蘭商菲林公司	用於控制性卵巢刺激之組成物及方法
US20220380785A1 (en) *	2019-11-01	2022-12-01	The University Of British Columbia	Compositions and methods for sialylated mucin-type o-glycosylation of therapeutic proteins
TW202237173A (zh)	2020-12-09	2022-10-01	荷蘭商菲林公司	用於受控的卵巢刺激之組成物及方法
KR20240167660A (ko)	2022-04-01	2024-11-27	훼링 비.브이.	불임의 치료를 위한 혼합 프로토콜
AU2023275943A1 (en)	2022-05-26	2024-10-17	Ferring B.V.	Compositions and methods for treatment of infertility in males
KR20250033230A (ko)	2022-07-08	2025-03-07	훼링 비.브이.	자궁내 인공수정(iui)을 위한 조성물 및 방법
AR133300A1 (es)	2023-07-20	2025-09-17	Ferring Bv	Micropartículas cargadas con fármaco de liberación prolongada

Family Cites Families (28)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
IT1206302B (it)	1987-06-26	1989-04-14	Serono Cesare Ist Ricerca	Ormone follicolo-stimolante urinario
US5541083A (en)	1989-10-24	1996-07-30	The Regents Of The University Of California	Method for producing secretable glycosyltransferases and other golgi processing enzymes
IL160406A0 (en)	1995-06-15	2004-07-25	Crucell Holland Bv	A cell harbouring nucleic acid encoding adenoritus e1a and e1b gene products
JP3559652B2 (ja) *	1996-06-25	2004-09-02	グローリー工業株式会社	売上精算システムの管理装置
IL122732A0 (en) *	1997-01-15	1998-08-16	Akzo Nobel Nv	Liquid gonadotropin-containing formulation its preparation and a device containing same
JP2001507215A (ja)	1997-01-16	2001-06-05	サイテルコーポレイション	組換え糖タンパク質のインビトロでの実用的なシアリル化
JPH1111665A (ja)	1997-06-28	1999-01-19	Shibuya Kogyo Co Ltd	無菌エア搬送コンベヤ装置
TWI235158B (en) *	1997-09-01	2005-07-01	Kirin Brewery	Human thrombopoietin produced by human established cell lines, processes foe preparing the same, and pharmaceutical composition comprising the same
PT1176976E (pt)	1999-05-07	2006-11-30	Applied Research Systems	Utilização de lh administrada na fase folicular média e tardia para o tratamento de mulheres anovulatórias.
JP2002011665A (ja)	2000-06-28	2002-01-15	Sintokogio Ltd	ショットブラスト装置モニタシステム
IL140110A0 (en)	2000-12-05	2002-02-10	Applied Research Systems	Improvement of homogeneity and secretion of recombinant proteins in mammalian systems
MEP38608A (en) *	2001-10-22	2011-02-10	Merck Serono Sa	Gonadotrophins for folliculogenesis
ATE542904T1 (de)	2001-10-29	2012-02-15	Crucell Holland Bv	Verfahren und mittel zur herstellung von proteinen mit vorbestimmten posttranslationalen modifikationen
PT1465987E (pt)	2001-12-07	2008-04-15	Crucell Holland Bv	Produção de vírus, isolados virais e vacinas
US20040248784A1 (en)	2003-06-03	2004-12-09	Marco Filicori	Unitary combinations of FSH and hCG
JP2007515410A (ja) *	2003-12-03	2007-06-14	ネオステクノロジーズインコーポレイテッド	ＧｌｙｃｏＰＥＧ化卵胞刺激ホルモン
ES2350298T3 (es)	2004-02-04	2011-01-20	Centre National De La Recherche Scientifique	Procedimiento para el cribado de anticuerpos específicos de glicoforma.
CN103627670B (zh) *	2004-02-13	2016-12-21	格莱克托普有限公司	高活性糖蛋白加工条件及其有效生产方法
TWI488640B (zh)	2008-04-16	2015-06-21	菲瑞茵國際中心股份有限公司	藥學製劑
TWI532495B (zh)	2009-10-05	2016-05-11	菲瑞茵國際中心股份有限公司	藥學製劑
EP2417982A1 (en)	2010-07-30	2012-02-15	Ferring B.V.	Stabilization of gonadotropins
US8790322B2 (en)	2010-08-03	2014-07-29	King Saud University	Stoma coat
WO2012016576A1 (en) *	2010-08-04	2012-02-09	Glycotope Gmbh	Improved recombinant human follicle-stimulating hormone
PT2621517E (pt)	2010-09-29	2015-10-16	Ferring Bv	Composição para uso no tratamento da infertilidade
PL2691119T3 (pl)	2011-03-31	2019-01-31	Ferring B.V.	Preparat farmaceutyczny
EP2717904A1 (en)	2011-06-06	2014-04-16	Ferring BV	Pharmaceutical preparation comprising recombinant fsh
JO3092B1 (ar)	2011-08-08	2017-03-15	Ferring Bv	مركب لتحفيز مسيطر عليه للمبيض
MX2016013449A (es)	2014-04-18	2017-05-04	Glycotope Gmbh	Hiperestimulacion ovarica controlada con la hormona estimuladora folicular humana recombinante mejorada.

2009
- 2009-04-15 TW TW098112483A patent/TWI488640B/zh active
- 2009-04-16 CN CN201510933827.2A patent/CN105906703A/zh active Pending
- 2009-04-16 HU HUE16179121A patent/HUE068565T2/hu unknown
- 2009-04-16 SI SI200930931T patent/SI2268666T1/sl unknown
- 2009-04-16 CN CN201510933782.9A patent/CN105906702A/zh active Pending
- 2009-04-16 NZ NZ588381A patent/NZ588381A/en unknown
- 2009-04-16 ES ES09733497.3T patent/ES2468318T3/es active Active
- 2009-04-16 FI FIEP16179121.5T patent/FI3098234T3/fi active
- 2009-04-16 SI SI200931670A patent/SI3045471T1/sl unknown
- 2009-04-16 SI SI200932209T patent/SI4015527T1/sl unknown
- 2009-04-16 LT LTEP14178729.1T patent/LT2808340T/lt unknown
- 2009-04-16 MX MX2017007881A patent/MX355457B/es unknown
- 2009-04-16 MX MX2014011348A patent/MX348622B/es unknown
- 2009-04-16 PL PL16194925T patent/PL3144318T3/pl unknown
- 2009-04-16 EP EP16158141.8A patent/EP3045471B1/en not_active Revoked
- 2009-04-16 LT LTEP16179121.5T patent/LT3098234T/lt unknown
- 2009-04-16 AR ARP090101333A patent/AR071479A1/es not_active Application Discontinuation
- 2009-04-16 JP JP2011504527A patent/JP2011519359A/ja active Pending
- 2009-04-16 PT PT161581418T patent/PT3045471T/pt unknown
- 2009-04-16 BR BRPI0910461A patent/BRPI0910461B8/pt active IP Right Grant
- 2009-04-16 ES ES16179121T patent/ES2989729T3/es active Active
- 2009-04-16 EP EP16194925.0A patent/EP3144318B1/en active Active
- 2009-04-16 KR KR1020167012148A patent/KR20160056960A/ko not_active Ceased
- 2009-04-16 FI FIEP21212873.0T patent/FI4015527T3/fi active
- 2009-04-16 MX MX2010011343A patent/MX2010011343A/es active IP Right Grant
- 2009-04-16 HU HUE21212873A patent/HUE071059T2/hu unknown
- 2009-04-16 PT PT97334973T patent/PT2268666E/pt unknown
- 2009-04-16 SI SI200932094T patent/SI3144318T1/sl unknown
- 2009-04-16 PT PT161949250T patent/PT3144318T/pt unknown
- 2009-04-16 WO PCT/GB2009/000978 patent/WO2009127826A1/en not_active Ceased
- 2009-04-16 DK DK14178729.1T patent/DK2808340T3/en active
- 2009-04-16 PL PL09733497T patent/PL2268666T3/pl unknown
- 2009-04-16 EP EP14178729.1A patent/EP2808340B1/en not_active Revoked
- 2009-04-16 SI SI200932205T patent/SI3098234T1/sl unknown
- 2009-04-16 RU RU2014141994A patent/RU2682270C2/ru active
- 2009-04-16 KR KR1020177026920A patent/KR20170110741A/ko not_active Ceased
- 2009-04-16 PL PL21212873.0T patent/PL4015527T3/pl unknown
- 2009-04-16 PT PT141787291T patent/PT2808340T/pt unknown
- 2009-04-16 PL PL16179121.5T patent/PL3098234T3/pl unknown
- 2009-04-16 RU RU2010141908/10A patent/RU2537268C2/ru active
- 2009-04-16 EP EP09733497.3A patent/EP2268666B1/en not_active Revoked
- 2009-04-16 PT PT212128730T patent/PT4015527T/pt unknown
- 2009-04-16 HU HUE16158141A patent/HUE033830T2/en unknown
- 2009-04-16 EP EP13193214.7A patent/EP2722339A1/en active Pending
- 2009-04-16 DK DK16194925.0T patent/DK3144318T3/da active
- 2009-04-16 DK DK09733497.3T patent/DK2268666T3/da active
- 2009-04-16 HU HUE14178729A patent/HUE030652T4/en unknown
- 2009-04-16 SI SI200931547A patent/SI2808340T1/sl unknown
- 2009-04-16 US US12/988,218 patent/US8951967B2/en active Active
- 2009-04-16 HR HRP20140535AT patent/HRP20140535T1/hr unknown
- 2009-04-16 PT PT161791215T patent/PT3098234T/pt unknown
- 2009-04-16 DK DK21212873.0T patent/DK4015527T3/da active
- 2009-04-16 KR KR1020107025581A patent/KR101622944B1/ko active Active
- 2009-04-16 LT LTEP21212873.0T patent/LT4015527T/lt unknown
- 2009-04-16 HR HRP20250313TT patent/HRP20250313T1/hr unknown
- 2009-04-16 ES ES21212873T patent/ES3023526T3/es active Active
- 2009-04-16 HR HRP20241187TT patent/HRP20241187T1/hr unknown
- 2009-04-16 DK DK16158141.8T patent/DK3045471T3/en active
- 2009-04-16 DK DK16179121.5T patent/DK3098234T3/da active
- 2009-04-16 AU AU2009237479A patent/AU2009237479B2/en active Active
- 2009-04-16 CA CA2725257A patent/CA2725257A1/en active Pending
- 2009-04-16 LT LTEP16158141.8T patent/LT3045471T/lt unknown
- 2009-04-16 ES ES16158141.8T patent/ES2629392T3/es active Active
- 2009-04-16 CN CN200980121391XA patent/CN102066414A/zh active Pending
- 2009-04-16 ES ES14178729.1T patent/ES2610277T3/es active Active
- 2009-04-16 KR KR1020197022294A patent/KR102108377B1/ko not_active Expired - Fee Related
- 2009-04-16 KR KR1020187023820A patent/KR20180095140A/ko not_active Ceased
- 2009-04-16 PL PL14178729T patent/PL2808340T3/pl unknown
- 2009-04-16 PL PL16158141T patent/PL3045471T3/pl unknown
- 2009-04-16 EP EP21212873.0A patent/EP4015527B1/en active Active
- 2009-04-16 EP EP16179121.5A patent/EP3098234B1/en active Active
- 2009-04-18 SA SA109300228A patent/SA109300228B1/ar unknown
2010
- 2010-10-07 IL IL208538A patent/IL208538A/en active Protection Beyond IP Right Term
- 2010-10-14 ZA ZA2010/07373A patent/ZA201007373B/en unknown
2014
- 2014-01-21 IL IL230571A patent/IL230571A/en active IP Right Grant
- 2014-06-06 CY CY20141100402T patent/CY1115413T1/el unknown
- 2014-06-17 AU AU2014203277A patent/AU2014203277C1/en active Active
- 2014-11-14 US US14/541,852 patent/US9546204B2/en active Active
- 2014-12-25 JP JP2014262056A patent/JP2015120696A/ja active Pending
2016
- 2016-08-16 US US15/238,362 patent/US9771407B2/en active Active
- 2016-10-07 JP JP2016198588A patent/JP6486310B2/ja active Active
- 2016-11-16 HR HRP20161520TT patent/HRP20161520T1/hr unknown
2017
- 2017-05-30 HU HUS1700024C patent/HUS1700024I1/hu unknown
- 2017-05-31 HU HUS1700025C patent/HUS1700025I1/hu unknown
- 2017-06-05 LT LTPA2017018C patent/LTPA2017018I1/lt unknown
- 2017-06-06 FR FR17C1020C patent/FR17C1020I2/fr active Active
- 2017-06-06 NO NO2017025C patent/NO2017025I1/no unknown
- 2017-06-23 AU AU2017204259A patent/AU2017204259B2/en active Active
- 2017-06-23 AU AU2017204258A patent/AU2017204258B2/en active Active
- 2017-06-26 HR HRP20170958TT patent/HRP20170958T1/hr unknown
- 2017-08-01 JP JP2017148823A patent/JP6762916B2/ja active Active
- 2017-08-29 US US15/690,061 patent/US10995128B2/en active Active
- 2017-09-05 AU AU2017225020A patent/AU2017225020B2/en active Active
- 2017-09-27 LT LTPA2017029C patent/LTPA2017029I1/lt unknown
- 2017-09-27 HU HUS1700036C patent/HUS1700036I1/hu unknown
- 2017-09-28 NO NO2017050C patent/NO2017050I1/no unknown
2018
- 2018-11-08 RU RU2018139379A patent/RU2745557C3/ru active Protection Beyond IP Right Term
2019
- 2019-10-25 JP JP2019194476A patent/JP7316905B2/ja active Active
2021
- 2021-04-30 US US17/246,348 patent/US11952407B2/en active Active
- 2021-10-27 JP JP2021175403A patent/JP2022031652A/ja active Pending
2023
- 2023-12-21 JP JP2023215339A patent/JP2024038000A/ja active Pending
2024
- 2024-03-14 US US18/605,381 patent/US12516094B2/en active Active
2025
- 2025-01-15 FI FIC20250003C patent/FIC20250003I1/fi unknown
- 2025-01-16 NO NO2025006C patent/NO2025006I1/no unknown
- 2025-01-16 FR FR25C1003C patent/FR25C1003I1/fr active Active
- 2025-01-24 LT LTPA2025505C patent/LTPA2025505I1/lt unknown
- 2025-01-28 HU HUS2500008C patent/HUS2500008I1/hu unknown
- 2025-07-02 FR FR25C1025C patent/FR25C1025I1/fr active Active
- 2025-07-07 LT LTPA2025525C patent/LTPA2025525I1/lt unknown
- 2025-07-07 HU HUS2500029C patent/HUS2500029I1/hu unknown
- 2025-07-11 FI FIC20250025C patent/FIC20250025I1/fi unknown
- 2025-07-14 NO NO2025032C patent/NO2025032I1/no unknown

Also Published As

Publication number	Publication date
KR20190092608A (ko)	2019-08-07
EP2268666B1 (en)	2014-03-12
US20240327487A1 (en)	2024-10-03
RU2682270C2 (ru)	2019-03-18
AU2017225020B2 (en)	2019-11-14
HRP20241187T1 (hr)	2024-12-06
AU2014203277C1 (en)	2017-07-27
HUS1700025I1 (hu)	2017-06-28
RU2014141994A3 (pt)	2018-05-28
US11952407B2 (en)	2024-04-09
JP2018021037A (ja)	2018-02-08
DK4015527T3 (da)	2025-04-14
CN105906703A (zh)	2016-08-31
ES2989729T3 (es)	2024-11-27
IL230571A (en)	2015-11-30
US9546204B2 (en)	2017-01-17
JP2020040956A (ja)	2020-03-19
AU2009237479A1 (en)	2009-10-22
HUS1700036I1 (hu)	2017-10-30
RU2014141994A (ru)	2016-05-10
PT3098234T (pt)	2024-10-21
ES2629392T3 (es)	2017-08-09
ES3023526T3 (en)	2025-06-02
RU2537268C2 (ru)	2014-12-27
SI3045471T1 (sl)	2017-07-31
BRPI0910461A2 (pt)	2018-03-27
AU2017225020A1 (en)	2017-09-28
PT2268666E (pt)	2014-06-25
US20150065695A1 (en)	2015-03-05
LT2808340T (lt)	2016-11-10
CY1115413T1 (el)	2017-01-04
IL208538A (en)	2014-03-31
US20110105398A1 (en)	2011-05-05
SI3144318T1 (sl)	2020-12-31
PT2808340T (pt)	2016-11-21
AU2009237479B2 (en)	2014-05-15
CN102066414A (zh)	2011-05-18
DK3045471T3 (en)	2017-06-26
US20180079794A1 (en)	2018-03-22
FR17C1020I2 (fr)	2020-04-10
HRP20250313T1 (hr)	2025-05-09
CA2725257A1 (en)	2009-10-22
US9771407B2 (en)	2017-09-26
EP3144318A1 (en)	2017-03-22
MX2010011343A (es)	2011-01-20
PL4015527T3 (pl)	2025-05-26
MX348622B (es)	2017-06-22
US20160347811A1 (en)	2016-12-01
US8951967B2 (en)	2015-02-10
EP2268666A1 (en)	2011-01-05
RU2745557C1 (ru)	2021-03-29
LT3045471T (lt)	2017-07-10
HUE068565T2 (hu)	2025-01-28
PT4015527T (pt)	2025-04-10
RU2745557C3 (ru)	2021-12-10
JP2017060476A (ja)	2017-03-30
AU2014203277A1 (en)	2014-07-24
SI4015527T1 (sl)	2025-05-30
FIC20250025I1 (fi)	2025-07-11
EP3045471B1 (en)	2017-03-29
DK2808340T3 (en)	2016-12-05
LT4015527T (lt)	2025-04-10
SI2808340T1 (sl)	2016-12-30
KR20170110741A (ko)	2017-10-11
KR102108377B1 (ko)	2020-05-08
HRP20161520T1 (hr)	2016-12-30
AU2017204258A1 (en)	2017-07-20
EP3045471A1 (en)	2016-07-20
EP3098234B1 (en)	2024-07-31
DK2268666T3 (da)	2014-05-12
NO2017050I1 (no)	2017-09-28
LTPA2025525I1 (pt)	2025-07-25
PL3098234T3 (pl)	2025-01-07
PT3045471T (pt)	2017-06-14
KR101622944B1 (ko)	2016-05-23
LTPA2017018I1 (lt)	2017-06-26
KR20180095140A (ko)	2018-08-24
FR25C1003I1 (fr)	2025-02-28
AU2017204259A1 (en)	2017-07-20
AU2014203277B2 (en)	2017-04-06
EP2808340B1 (en)	2016-08-17
CN105906702A (zh)	2016-08-31
JP2015120696A (ja)	2015-07-02
ZA201007373B (en)	2011-06-29
HK1199039A1 (en)	2015-06-19
JP6762916B2 (ja)	2020-09-30
NO2025032I1 (no)	2025-07-14
DK3098234T3 (da)	2024-10-21
PL2268666T3 (pl)	2014-08-29
JP2022031652A (ja)	2022-02-22
HUE030652T4 (en)	2017-09-28
EP3098234A1 (en)	2016-11-30
HUE030652T2 (en)	2017-05-29
US12516094B2 (en)	2026-01-06
SI3098234T1 (sl)	2024-10-30
EP2808340A1 (en)	2014-12-03
TWI488640B (zh)	2015-06-21
RU2010141908A (ru)	2012-05-27
PL2808340T3 (pl)	2017-02-28
NZ588381A (en)	2012-05-25
DK3144318T3 (da)	2020-12-07
EP2722339A1 (en)	2014-04-23
FI3098234T3 (fi)	2024-10-31
BRPI0910461B8 (pt)	2021-05-25
JP7316905B2 (ja)	2023-07-28
ES2610277T3 (es)	2017-04-26
HK1146284A1 (en)	2011-05-20
AU2017204258B2 (en)	2017-08-17
EP4015527A1 (en)	2022-06-22
PL3045471T3 (pl)	2017-10-31
PL3144318T3 (pl)	2021-02-08
JP2024038000A (ja)	2024-03-19
FR17C1020I1 (pt)	2020-04-10
HUE033830T2 (en)	2018-01-29
EP3144318B1 (en)	2020-09-23
LTPA2025505I1 (pt)	2025-02-10
JP2011519359A (ja)	2011-07-07
TW200948378A (en)	2009-12-01
KR20160056960A (ko)	2016-05-20
US10995128B2 (en)	2021-05-04
WO2009127826A1 (en)	2009-10-22
AR071479A1 (es)	2010-06-23
HRP20170958T1 (hr)	2017-09-22
HRP20140535T1 (hr)	2014-07-18
JP6486310B2 (ja)	2019-03-20
KR20110005863A (ko)	2011-01-19
NO2017025I1 (no)	2017-06-06
HUS2500029I1 (hu)	2025-07-28
FIC20250003I1 (fi)	2025-01-15
FI4015527T3 (fi)	2025-04-29
HUS2500008I1 (hu)	2025-02-28
EP4015527B1 (en)	2025-01-22
MX355457B (es)	2018-04-19
SA109300228B1 (ar)	2014-04-08
NO2025006I1 (no)	2025-01-16
PT3144318T (pt)	2020-11-04
ES2468318T3 (es)	2014-06-16
BRPI0910461B1 (pt)	2021-02-23
FR25C1025I1 (fr)	2025-09-19
HUE071059T2 (hu)	2025-07-28
SI2268666T1 (sl)	2014-07-31
AU2017204259B2 (en)	2017-08-17
IL208538A0 (en)	2010-12-30
HUS1700024I1 (hu)	2017-06-28
LT3098234T (lt)	2024-09-10
US20210332099A1 (en)	2021-10-28
LTPA2017029I1 (lt)	2017-10-10

Legal Events

Date	Code	Title	Description
2018-04-17	B06F	Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
2018-10-02	B07D	Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]	Free format text: DE ACORDO COM O ARTIGO 229-C DA LEI NO 10196/2001
2019-12-03	B07E	Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]
2020-02-27	B06U	Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette]
2020-09-24	B06A	Patent application procedure suspended [chapter 6.1 patent gazette]
2021-01-05	B09A	Decision: intention to grant [chapter 9.1 patent gazette]
2021-02-23	B16A	Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]	Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 23/02/2021, OBSERVADAS AS CONDICOES LEGAIS.
2021-05-25	B16C	Correction of notification of the grant [chapter 16.3 patent gazette]	Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 16/04/2009 OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF

Publication	Publication Date	Title
BRPI0910461A8 (pt)	2018-10-16	hormônio de estimulação do folículo recombinante, sua composição farmacêutica, seu método de produção e seu uso.
BRPI0924177A2 (pt)	2015-08-18	Polipeptídeos, seu método de preparação, sua composição, sequência de nucleotídeo e uso
BR112013019083A2 (pt)	2017-04-04	combinação de (a) um imunoconjugado, composição farmacêutica, uso de (a) um imunoconjugado, método de tratamento de uma doença em um individuo, método de estímulo de função celular efetora em um indivíduo e kit destinado ao tratamento de uma doença.
BRPI1010621A2 (pt)	2016-06-21	derivado de imidazoquinolinonas, sua composição farmacêutica e seu uso
BRPI1008145A2 (pt)	2016-03-15	proteína de ligação de antígeno biespecífico, método para preparação de uma proteína de ligação de antígeno biespecífico, célula hospedeira, composição farmacêutica, uso da proteína de ligação de antígeno biespecífico e método para o tratamento de um paciente.
BR112012004335A2 (pt)	2015-09-08	composto, composição farmacêutica, e, uso do composto.
BR112012022879A2 (pt)	2016-06-14	composto, composição farmacêutica, uso do composto e método de tratamento
IL215603A0 (en)	2011-12-29	Human protein scaffold with controlled serum pharmacokinetics, compositions comprising the same and uses thereof
BRPI0813897A2 (pt)	2014-12-30	Uso de uma substância, composição cosmética ou dermo-cosmética ou neutracêutica, composição farmacêutica, método de cuidado cosmético, e, seqüência de nucleotídeos.
BRPI0918502A2 (pt)	2015-12-01	aminoindanos substituídos e análogos dos mesmos, e o uso farmacêutico dos mesmos
BRPI0819714A2 (pt)	2015-05-26	Formulações de proteína e métodos de produção das mesmas.
BRPI0816097A2 (pt)	2016-11-01	composição farmacêutica, método para tratar eritema em um paciente com rosácea, e, uso de uma composição.
BRPI0924183A2 (pt)	2016-07-05	inibidores de proteína quinase, formas cristalinas, formulações farmacêuticas e uso
BRPI1010768A2 (pt)	2016-11-01	composto, e, composição farmacêutica.
BRPI1011423A2 (pt)	2016-03-15	composição injetável, kit e método cosmético.
BR112014022788A2 (pt)	2017-11-14	peptídeo, polipeptídeos, ácido nucleico, composição farmacêutica, conjugado e método in vitro
BRPI0915552A2 (pt)	2017-06-20	derivados de ciclosporina, seu uso e sua composição farmacêutica
BRPI1011043A2 (pt)	2016-09-13	compostos de fenilureias e fenilamidas substituídas como ligantes de receptor de vaniloide, sua composição farmacêutica, seu uso e seu processo de preparação.
BRPI1015983A2 (pt)	2016-04-19	composto, uso do composto, método para tratar um paciente, e, composição farmacêutica.
BRPI0922233A2 (pt)	2018-05-29	compostos, composições farmacêiticas e métodos para uso no tratamento de síndromes metabólicas.
DK2238110T3 (da)	2012-02-20	5.6-bisaryl-2-pyridin-carboxamid-derivater, fremstilling heraf og terapeutisk anvendelse heraf som urotensin II-receptorantagonister
BRPI1006996A2 (pt)	2015-09-15	composição, método e uso
BRPI0921717A2 (pt)	2018-10-09	composto, sequência de peptídeo isolada, composição farmacêutica, uso de um composto, anticorpo, e, método de tratamento
BRPI0911772A2 (pt)	2017-06-27	composto, composição farmacêutica, e, uso do composto.
BRPI0720323A2 (pt)	2016-08-09	composto, método de tratamento, composição farmacêutica e uso do composto